Sublobar Resection Should Be New Standard Care for Certain Patients With NSCLC
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
Recent exposure to systemic treatment does not increase the risk of 30-day mortality in patients with thoracic cancers and COVID-19.
Long-term cumulative exposure to air pollution should be included in assessments of lung cancer risk, according to researchers.
Consent forms could be improved by a patient-centric addendum highlighting key points, a study suggests.
Adding pembrolizumab to chemotherapy can improve survival in extensive-stage small cell lung cancer, a phase 3 study suggests.
Researchers found that 77% of patients had moderate to severe sexual dysfunction.
Advanced disease at diagnosis is more likely among younger patients with non-small cell lung cancer, according to a new study.
COVID-19 vaccination does not appear to prevent SARS-CoV-2 infection in patients with lung cancer, but it may prevent severe COVID-19.
Sugemalimab consolidation improved progression-free survival, when compared with placebo, in patients with unresectable, stage III non-small cell lung cancer.
Adding nivolumab to neoadjuvant platinum-based chemotherapy can improve survival in patients with stage IIIA-B non-small cell lung cancer, new data suggest.